ABBV Abbvie Inc

Price (delayed)

$293.61

Market cap

$518.99B

P/E Ratio

50.36

Dividend/share

$6.92

EPS

$5.83

Enterprise value

$589.12B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 78

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Highlights
The company's net income has surged by 64% QoQ
The EPS has soared by 64% from the previous quarter
Abbvie's equity has plunged by 75% YoY but it has increased by 23% from the previous quarter
The debt rose by 18% year-on-year and by 14% since the previous quarter

Key stats

What are the main financial stats of ABBV

ABBV stock price

How has the Abbvie stock price performed over time
Intraday
-0.46%
1 week
1.86%
1 month
4.44%
1 year
25.89%
YTD
28.5%
QTD
12.24%

Financial performance

How have Abbvie's revenue and profit performed over time
Revenue
$66.01B
Gross profit
$48.67B
Operating income
$21.23B
Net income
$10.34B
Gross margin
73.7%
Net margin
15.7%
The operating income has soared by 135% YoY and by 26% from the previous quarter
The operating margin has surged by 112% year-on-year and by 23% since the previous quarter
The company's net income has surged by 64% QoQ
The net margin has surged by 60% since the previous quarter

Price vs fundamentals

How does ABBV's price correlate with its fundamentals

Growth

What is Abbvie's growth rate over time

Valuation

What is Abbvie stock price valuation
P/E
50.36
P/B
N/A
P/S
7.87
EV/EBIT
38.04
EV/EBITDA
25.44
EV/Sales
8.92
The EPS has soared by 64% from the previous quarter
ABBV's P/E is 37% below its last 4 quarters average of 79.8 and 15% below its 5-year quarterly average of 59.7
Abbvie's equity has plunged by 75% YoY but it has increased by 23% from the previous quarter
ABBV's P/S is 41% above its 5-year quarterly average of 5.6 and 18% above its last 4 quarters average of 6.7
ABBV's revenue is up by 11% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is Abbvie business performance
Abbvie's return on assets has surged by 60% QoQ
The ROS has grown by 34% from the previous quarter
Abbvie's ROIC has increased by 30% from the previous quarter

Dividends

What is ABBV's dividend history
DPS
$6.92
Dividend yield
2.36%
Payout ratio
118.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbvie financials performed over time
Abbvie's total assets is 3% lower than its total liabilities
ABBV's current ratio is up by 21% year-on-year and by 7% since the previous quarter
The quick ratio has grown by 19% YoY and by 14% from the previous quarter
Abbvie's equity has plunged by 75% YoY but it has increased by 23% from the previous quarter
The company's debt to equity fell by 48% QoQ but it rose by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.